Stocksigma LogoStocksigma Logo

Saptak Chem: No Deviation in Use of Preferential Issue Proceeds

Saptak Chem and Business Limited confirmed no deviation in utilizing funds from its preferential issue of convertible warrants for the quarter ended 30

Saptak Chem: No Deviation in Use of Preferential Issue Proceeds

Saptak Chem And Business Ltd 路 Others (Uncategorized) 路 01 Aug 2026, 11:55 pm

Saptak Chem: No Deviation in Use of Preferential Issue Proceeds Saptak Chem and Business Limited confirmed no deviation in utilizing funds from its preferential issue of convertible warrants for the quarter ended 30 Jun'26. The company raised Rs 4.20 crore via the issuance of 40 lakh warrants at Rs 10.50 each. As of the reporting date, it has received Rs 1.05 crore (25% consideration) and utilized Rs 1.57 crore towards working capital requirements. The Audit Committee reviewed the utilization statement and noted no variations from the stated objectives.

Original exchange filing (PDF)

More announcements from Saptak Chem And Business Ltd

All Saptak Chem And Business Ltd announcements